Copyright
©The Author(s) 2022.
World J Gastroenterol. Aug 14, 2022; 28(30): 4089-4101
Published online Aug 14, 2022. doi: 10.3748/wjg.v28.i30.4089
Published online Aug 14, 2022. doi: 10.3748/wjg.v28.i30.4089
Discovery set | Validation set | |||||
CD | UC | HC | CD | UC | HC | |
N | 50 | 50 | 50 | 50 | 50 | 50 |
Gender (female, male) | 29, 21 | 29, 21 | 29, 21 | 28, 22 | 28, 22 | 28, 22 |
Age (median ± SD) | 41 ± 17.66 | 44 ± 17.25 | 42 ± 18.47 | 39.5 ± 17.49 | 44.5 ± 17.23 | 39.5 ± 16.02 |
Disease behavior (B1/B2/B3) | 9/10/6 | 16/8/2 | ||||
Disease location (L1/L2/L3/L4) | 12/6/7/0 | 12/7/7/0 | ||||
Disease extent (E1/E2/E3) | 0/32/18 | 0/34/16 | ||||
Surgery (Yes, No) | 24, 25 | 8, 42 | 22, 27 | 7, 42 |
- Citation: Shome M, Song L, Williams S, Chung Y, Murugan V, Park JG, Faubion W, Pasha SF, Leighton JA, LaBaer J, Qiu J. Serological profiling of Crohn’s disease and ulcerative colitis patients reveals anti-microbial antibody signatures. World J Gastroenterol 2022; 28(30): 4089-4101
- URL: https://www.wjgnet.com/1007-9327/full/v28/i30/4089.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i30.4089